Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
Clinical trial NCT05462496 · RECRUITING
Trial details
- NCT number
- NCT05462496
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-16
- Primary completion
- 2027-08-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.